U.S. Biosimilars Market Analysis, Size, Share, and Forecast 2031
The U.S. Biosimilars Market in 2023 is US$ 13.27 billion, and is expected to reach US$ 200.59 billion by 2031 at a CAGR of 40.40%.

The U.S. Biosimilars Market in 2023 is US$ 13.27 billion, and is expected to reach US$ 200.59 billion by 2031 at a CAGR of 40.40%.